Beyza Soylu

Beyza Soylu

Auto-generated profile, based on publicly available information

Beyza Soylu

Department of Internal Medicine, Health Sciences University Kanuni Sultan Süleyman Training & Research Hospital, İstanbul, 34303, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2021 in Biomarkers in Medicine
Verified
Journal Article
Open access
MBMehmet Bayram
Mehmet Bayram
OYOzgur Yildirim
Ozgur Yildirim
RORaye S Ozmen
Raye S Ozmen
BSBeyza Soylu
Beyza Soylu
ADAhmet S Dundar
Ahmet S Dundar
OTOmur Tabak
Omur Tabak
Aim: In our study, we investigated the efficiency of the prognostic nutritional index (PNI) score and the CRP, age, platelet count, albumin level (CAPA) score predicting mortality and intensive car... Lay abstract The COVID-19 pandemic is a global health problem that affects all societies. In order to deal with this urgent situation, the rapid spread of the disease in outbreaks requires categori...

5 September 2021 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
PDF file
ÖYÖzgür Yildirim
Özgür Yildirim
MBMehmet Bayram
Mehmet Bayram
RÖRaye Sevra Özmen
Raye Sevra Özmen
BSBeyza Soylu
Beyza Soylu
ADAhmet Said Dündar
Ahmet Said Dündar
OTOmur Tabak
Omur Tabak
Introduction: The COVID-19 pandemic has shown that patients should be categorized according to their risk group, patient follow-up and the use of health resources should be arranged according to this categorization. Therefore, practical and inexpensive biomarkers are needed. In this study, the relationship between neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), mean platelet volume (MPV) and red blood cell distribution width (RDW) levels, which can be easily calculated by complete blood count, with mortality and intensive care unit (ICU) admission in COVID-19 disease was evaluated. Materials and Methods: 748 inpatients with positive COVID-19 PCR test were evaluated retrospectively. The NLR, PLR, MPV and RDW levels calculated from the complete blood count parameters of the patients at hospital admissions and their relationship with the mortality and the ICU admission in COVID-19 disease were evaluated. Results: In terms of mortality, a statistically significant difference was found between RDW levels in the evaluation performed in the patient groups who survived and died (p: 0.014). No statistically significant difference was found in NLR, PLR and MPV levels. In the evaluation made between ICU (+) and ICU (-) groups, a statistically significant difference was found in RDW and NLR levels (p: 0.042, p: 0.01, respectively). There was no statistically significant difference between PLR and MPV levels for ICU admission. Conclusion: RDW level was found to be associated with COVID-19 related mortality and ICU admission.